Noriko Yoshimura1, Tatsunari Sasada1, Shuji Yonehara2. 1. Department of Surgery, Onomichi General Hospital, Hiroshima, Japan. 2. Department of Pathology, Onomichi General Hospital, Hiroshima, Japan.
Abstract
BACKGROUND: Primary large-cell neuroendocrine carcinoma of the breast (LCNEC-breast) in pre-menopausal women is extremely rare. CASE REPORT: A 34-year-old woman presented with a mass in the left breast that was diagnosed as neuroendocrine carcinoma by needle biopsy. Computed tomography revealed no lymph node swelling or distant organ metastasis. Left mastectomy and sentinel lymph node biopsy were performed and metastasis to the axial lymph node was detected. Left axillary lymph node dissection was performed and histopathological and immunohistochemical examination revealed that the tumor was an LCNEC-breast, which was 6.0 cm in size and positive for the neuroendocrine markers (neuron-specific enolase, chromogranin A, and synaptophysin). The tumor cells were hormone-receptor positive and HER2 negative. The patient refused any adjuvant hormonal therapy, chemotherapy or radiotherapy. She has been followed up for 4 years without medication, and no recurrence has been noted. CONCLUSION: We present a case of LCNEC-breast in a 34-year-old woman. Our case represents the youngest woman with LCNEC-breast reported in the English literature.
BACKGROUND: Primary large-cell neuroendocrine carcinoma of the breast (LCNEC-breast) in pre-menopausal women is extremely rare. CASE REPORT: A 34-year-old woman presented with a mass in the left breast that was diagnosed as neuroendocrine carcinoma by needle biopsy. Computed tomography revealed no lymph node swelling or distant organ metastasis. Left mastectomy and sentinel lymph node biopsy were performed and metastasis to the axial lymph node was detected. Left axillary lymph node dissection was performed and histopathological and immunohistochemical examination revealed that the tumor was an LCNEC-breast, which was 6.0 cm in size and positive for the neuroendocrine markers (neuron-specific enolase, chromogranin A, and synaptophysin). The tumor cells were hormone-receptor positive and HER2 negative. The patient refused any adjuvant hormonal therapy, chemotherapy or radiotherapy. She has been followed up for 4 years without medication, and no recurrence has been noted. CONCLUSION: We present a case of LCNEC-breast in a 34-year-old woman. Our case represents the youngest woman with LCNEC-breast reported in the English literature.
Entities:
Keywords:
Breast cancer; Large cell neuroendocrine carcinoma; Neuroendocrine tumor
Authors: Kjell Oberg; Oriol Casanovas; Justo P Castaño; Daniel Chung; Gianfranco Delle Fave; Patrice Denèfle; Philip Harris; Mohid S Khan; Matthew H Kulke; Aldo Scarpa; Laura H Tang; Bertram Wiedenmann Journal: Clin Cancer Res Date: 2013-03-04 Impact factor: 12.531
Authors: Jin Woo Kim; Ok Hee Woo; Kyu Ran Cho; Bo Kyung Seo; Hwan Seok Yong; Aeree Kim; Eun-Young Kang Journal: J Korean Med Sci Date: 2008-12-23 Impact factor: 2.153
Authors: Elena Trevisi; Anna La Salvia; Lorenzo Daniele; Maria Pia Brizzi; Giovanni De Rosa; Giorgio V Scagliotti; Massimo Di Maio Journal: Med Oncol Date: 2020-07-25 Impact factor: 3.064